Lupin Mira 25 Tablet ER

Introduction

Lupin Mira 25 Tablet ER is an extended-release medication used primarily to treat high blood pressure (hypertension) and other cardiovascular conditions. It contains the active ingredient, Mirtazapine, which works by relaxing blood vessels and improving blood flow, thus reducing blood pressure. The extended-release (ER) formulation ensures a steady release of the medication over time, providing consistent therapeutic effects throughout the day, which helps in managing long-term hypertension effectively.

Uses of Lupin Mira 25 Tablet ER

Lupin Mira 25 Tablet ER is used for:

• Managing high blood pressure (hypertension)
• Reducing the risk of heart-related complications such as stroke or heart attack
• Improving cardiovascular health by maintaining stable blood pressure levels

How Lupin Mira 25 Tablet ER Works

Lupin Mira 25 Tablet ER contains Mirtazapine, which works by relaxing the blood vessels and improving blood circulation. This results in a reduction in blood pressure and less strain on the heart. The extended-release formulation allows for continuous action, providing prolonged control of blood pressure throughout the day.

Benefits of Lupin Mira 25 Tablet ER

The benefits of Lupin Mira 25 Tablet ER include:

• Effective management of high blood pressure
• Reduced risk of heart attack, stroke, and kidney damage
• Continuous and stable blood pressure control with the extended-release formulation
• Improved overall cardiovascular health

How to Take Lupin Mira 25 Tablet ER

Take Lupin Mira 25 Tablet ER exactly as prescribed by your doctor, typically once a day. It should be taken with or without food, but always swallow the tablet whole with a glass of water. Do not chew, crush, or break the tablet, as this can affect its extended-release properties. Follow your doctor's instructions regarding dosage adjustments and blood pressure monitoring.

Side Effects of Lupin Mira 25 Tablet ER

Common side effects include:

• Dizziness or lightheadedness
• Headache
• Fatigue or tiredness
• Dry mouth

Serious side effects (rare):

• Severe allergic reactions (rash, swelling, difficulty breathing)
• Chest pain or irregular heartbeat
• Signs of liver problems (yellowing of the skin or eyes, dark urine)

If you experience any severe side effects, seek immediate medical attention.

Safety Advice

Consider the following precautions while using Lupin Mira 25 Tablet ER:

• Inform your doctor about any history of heart, liver, or kidney diseases
• Avoid alcohol, as it can increase the risk of side effects such as dizziness
• Monitor your blood pressure regularly to ensure the medication is working effectively
• Do not stop taking Lupin Mira 25 Tablet ER suddenly without consulting your doctor, as this may cause your blood pressure to rise
• Consult your doctor if you are pregnant, planning to conceive, or breastfeeding before using this medication

Frequently Asked Questions

Q: Can Lupin Mira 25 Tablet ER be used for conditions other than hypertension?
A: Lupin Mira 25 Tablet ER is primarily used for hypertension, but your doctor may prescribe it for other cardiovascular conditions depending on your individual needs.

Q: Can I take Lupin Mira 25 Tablet ER with other blood pressure medications?
A: Inform your doctor about all other medications you are taking, as combining them with Lupin Mira 25 Tablet ER may require dosage adjustments.

Q: How long does it take for Lupin Mira 25 Tablet ER to lower blood pressure?
A: You may begin to notice a reduction in blood pressure within a few days of starting treatment, but full effects may take several weeks to be realized.

Q: Is it safe to take Lupin Mira 25 Tablet ER if I am elderly?
A: Yes, but elderly patients may require closer monitoring for any side effects or complications related to blood pressure or organ function.

Q: What should I do if I miss a dose of Lupin Mira 25 Tablet ER?
A: If you miss a dose, take it as soon as you remember. If it's close to your next dose, skip the missed dose—do not take two doses at once to make up for the missed one.